Letters to the Editor
medical cannabis

Medical cannabis

Share
By: Amanda Francisco, BSN, RN

In 2017, according to the Centers for Disease Control and Prevention, the opioid epidemic caused 70,237 deaths. Of those 70,237 deaths, 47,600 were directly related to opioid prescription medications. The United States is looking for an answer to the opioid epidemic while providers are still attempting to treat patients with chronic pain. Prior to 1936, medical cannabis was legal in the United States and was sold over the counter (NCSBN). Cannabis was used as early as 1400 BC for chronic pain and other ailments (Hand and colleagues 2016)

I currently work in the geriatric community as an ambulatory care coordinator and have witnessed firsthand the challenges—Controlled Substances Act forms, drug toxicity screenings—that our patients (including those who are home-bound) face to obtain their opioid medications. With medical cannabis, the patient does not need to perform any of these tasks to maintain pain control. Additionally, very few CB1 receptors are found in the brainstem or the cardiorespiratory centers, making a lethal dose of cannabis impossible (Theisen and Konieczny). This creates an extra layer of protection for our seniors.

One of the biggest barriers to bringing medical cannabis to more patients and decreasing opioid prescription rates is lack of education. Medical providers, although interested and intrigued by medical cannabis, still do not have adequate research to feel confident about recommending it. By educating more providers and creating a level of comfort, the nurse can help decrease other medication prescriptions.

Amanda Francisco, BSN, RN

References

Centers for Disease Control and Prevention. Drug overdose deaths. March 3, 2021. cdc.gov/drugoverdose/data/statedeaths.html

Hand A, Blake A, Kerrigan P, Samuel P, Friedberg J. (2016). History of cannabis. J Pain Manage. 2016;9(4):387-94.

NCSBN Medical Marijuana Nursing Guidelines Committee. Guidelines for medical marijuana. Journal Nurs Regul. 2018. ncsbn.org/The_NCSBN_National_Nursing_Guidelines_for_Medical_Marijuana_JNR_July_2018.pdf

Theisen E, Konieczny E. Medical cannabis: What nurses need to know. Am Nurse Today. 2019;14(11):6-11.

 

Are you interested in sharing your input?
Please consider sending an electronic Letter to the Editor to share your opinion on American Nurse Journal content.

What are the guidelines for letter submissions?
Letters should be fewer than 275 words and take as their starting point an article published in American Nurse Journal in the past 2 months. Letters should be exclusive to American Nurse Journal and not submitted to or published in any other media. They must include the writer’s full name. Anonymous letters and letters written under pseudonyms will not be considered. Writers should disclose any personal or financial interest in the subject matter of their letters. Letters should not contain attachments.

Letters are screened prior to approval for posting; not all will be posted. We do not respond to requests for medical or legal advice. No material is intended to be a substitute for professional medical and legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary cause of postpartum hemorrhage?

Recent Posts